Association between dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 receptor agonists and COVID-19 infection and adverse outcomes: a cohort study

Contributors: Concept and design: all authors (WT, BY, JP, JF, LEF-L, PCA, CJ, HR, DSL, AW, MEF, ASG, CLA, JCK, AH, VD, JU). Data analysis: BY, JP, JF, LEF-L, WT, PCA, JU. Interpretation of data: all authors (WT, BY, JP, JF, LEF-L, PCA, CJ, HR, DSL, AW, MEF, ASG, CLA, JCK, AH, VD, JU). Drafting: WT and JU. Critical revisions: all authors (WT, BY, JP, JF, LEF-L, PCA, CJ, HR, DSL, AW, MEF, ASG, CLA, JCK, AH, VD, JU). Approval of manuscript: all authors (WT, BY, JP, JF, LEF-L, PCA, CJ, HR, DSL, AW, MEF, ASG, CLA, JCK, AH, VD, JU). Guarantor: JU.

Funding: This work was funded by the Ted Rogers Centre for Heart Research Innovation Fund COVID-19 award and a Canadian Institute for Health Research Strategy for Patient-Oriented Research Innovative Clinical Trial grant (MYG-151211).

Competing interests: JU has received speaker/consulting honoraria from Amgen, Boehringer Ingelheim, Janssen, Merck, Novartis, Sanofi, and grant support to his institutions from AstraZeneca, Bayer, Boehringer Ingelheim, Janssen, Novartis, Sanofi. DSL is the Ted Rogers Chair in Heart Function Outcomes, University Health Network, University of Toronto. MEF is the Peter Munk Chair in Multinational Clinical Trials at Peter Munk Cardiac Centre, University Health Network, University of Toronto. VD has received research grants from AstraZeneca.

Patient and public involvement statement: Patients or the public were not involved in the design, conduct, reporting, or dissemination of our research.

Supplemental material: This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.